Kemin Launches MEVAC™ MULTI ADENO Vaccine for Fowl Adenovirus in Thailand

Kemin Launches MEVAC^™ MULTI ADENO Vaccine for Fowl Adenovirus in Thailand

Inactivated tetravalent vaccine strengthens breeder protection in Southeast Asia

DES MOINES, Iowa, U.S. (April 1, 2026) – Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has expanded its breeder‑focused poultry vaccine portfolio across Southeast Asia with the launch of MEVAC^™ MULTI ADENO in Thailand.

MEVAC^™ MULTI ADENO provides broad protection by targeting multiple Fowl Adenoviruses (FAdVs) serotypes responsible for Inclusion Body Hepatitis (IBH) and Hydropericardium Hepatitis Syndrome (HPS), two economically significant diseases caused by FadVs that continue to challenge producers worldwide.

• Breeder health programs in Thailand have been in need of stronger, more comprehensive protection against Adenovirus challenges, and with MEVAC^™ MULTI ADENO now available, Kemin Biologics—the animal vaccine business unit of Kemin Industries—can support breeders with a robust solution that is also practical for local standards.

“This latest addition to our breeder vaccine portfolio reflects our commitment to equip producers with solutions that strengthen flock resilience, safeguard productivity, and support long‑term sustainability,” said Francisco Monsalve, Global Brand Manager, Kemin Biologics. “With MEVAC^™ MULTI ADENO, Kemin reinforces its leadership in providing relevant vaccines that help poultry operations stay ahead of immunosuppression disease pressures.”

Kemin Biologics is strengthening its footprint in the global vaccine market with solutions that help producers manage disease more effectively. The launch of MEVAC^™ MULTI ADENO in Thailand underscores the business unit’s commitment to provide high-quality vaccines that meet the highest standards of safety and efficacy.  

“The introduction of MEVAC^™ MULTI ADENO in Thailand marks an important step in strengthening the immunity of parent stock,” said Dr. Wei Shen Tong, Regional Technical Service Manager, Kemin Biologics. “As one of Asia’s leading poultry‑producing countries, Thailand benefits greatly from access to reliable and effective vaccines that protect avian health and help maintain stable supply chains.”

Kemin Biologics provides up‑to‑date vaccine solutions that help veterinarians manage the risks of endemic and emerging diseases so producers can continue feeding the world.

About Kemin Industries

Kemin Industries (www.kemin.com) is a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services. The company supplies over 500 specialty ingredients for human and animal health and nutrition, pet food, aquaculture, nutraceutical, food technologies, crop technologies, textile, biofuel, and animal vaccine industries.

For over half a century, Kemin has been dedicated to using applied science to address industry challenges and offer product solutions to customers in more than 120 countries. Kemin provides ingredients to feed a growing population with its commitment to the quality, safety and efficacy of food, feed, and health-related products.

Established in 1961, Kemin is a privately held, family-owned-and-operated company with more than 3,000 global employees and operations in 90 countries, including manufacturing facilities in Belgium, Brazil, China, Egypt, India, Italy, San Marino, Singapore, South Africa, and the United States.